Recruitment/Treatment of Minority Patients on Cancer Trials at Mayo Clinic

Overview

About this study

The short-term goal of this study is to inform the process and mechanisms to enrich URM patient accrual to interventional cancer treatment trials. The long-term goal is to build a patient-centered cancer practice and clinical trial patient population that is reflective of the diverse communities served by Mayo Clinic.

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • Under-represented minority (Black/African American, Native Hawaiian/Pacific Islander, Native American/Alaska native, more than 1 race, and Hispanic/LatinX).
  • Received cancer care on an interventional treatment clinical trial at Mayo Clinic (enterprise-wide) between 2018-2020. 
  • Consent to participate (for the survey and interview components).

Exclusion Criteria:

  • No specific exclusion criteria. 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Katharine Price, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions